• T. S. Dharmarajan
  • T. S. Dharmarajan
  • T. S. Dharmarajan
  • T. S. Dharmarajan
  • David Widjaja
  • C. S. Pitchumoni
  • C. S. Pitchumoni
  • C. S. Pitchumoni


Constipation is a common syndrome in older individuals. Constipation is defined as a frequency of defecation fewer than three times per week in association with additional manifestations as defined in the Rome criteria. Deviations from baseline habits deserve attention and perhaps evaluation. Motility and structural abnormalities are two important factors contributing to pathogenesis of constipation. Colonic motor dysfunction is associated with several factors, predominantly dietary, medication, and disease. A thorough medical history helps identify etiology and helps management of constipation. More specialized tests of colonic transit or pelvic floor function are considered in older adults in selected cases and in the settings where the findings influence management decisions. Management strategy includes life style modification, use of fiber, pharmacologic measures, and rarely miscellaneous modalities.


  1. 1.
    World Gastroenterology Organisation global guideline: constipation—a global perspective. J Clin Gastroenterol. 2011;45:483–7.Google Scholar
  2. 2.
    American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100 Suppl 1:S1–4.Google Scholar
  3. 3.
    Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am. 2009;38:463–80.PubMedGoogle Scholar
  4. 4.
    Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011;106:835–42; quiz 843.Google Scholar
  5. 5.
    Foxx-Orenstein AE, McNally MA, Odunsi ST. Update on constipation: one treatment does not fit all. Cleve Clin J Med. 2008;75:813–24.PubMedGoogle Scholar
  6. 6.
    Locke III GR, Pemberton JH, Phillips SF. American Gastroenterological Association medical position statement: guidelines on constipation. Gastroenterology. 2000;119:1761–6.PubMedGoogle Scholar
  7. 7.
    Tariq S. Constipation in long-term care. Ann Longterm Care. 2008;16:1–45.Google Scholar
  8. 8.
    Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96:3130–7.PubMedGoogle Scholar
  9. 9.
    Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health. 1990;80:185–9.PubMedGoogle Scholar
  10. 10.
    Harari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med. 1996;156:315–20.PubMedGoogle Scholar
  11. 11.
    Talley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993;105:781–90.PubMedGoogle Scholar
  12. 12.
    Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–80.PubMedGoogle Scholar
  13. 13.
    Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91:19–25.PubMedGoogle Scholar
  14. 14.
    Rao SS, Go JT. Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging. 2010;5:163–71.PubMedGoogle Scholar
  15. 15.
    Gage H, Goodman C, Davies SL, et al. Laxative use in care homes. J Adv Nurs. 2010;66:1266–72.PubMedGoogle Scholar
  16. 16.
    van Dijk KN, de Vries CS, van den Berg PB, et al. Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. Br J Clin Pharmacol. 1998;46:255–61.PubMedGoogle Scholar
  17. 17.
    Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea—common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol. 2010;11:2.Google Scholar
  18. 18.
    Martin BC, Barghout V, Cerulli A. Direct medical costs of constipation in the United States. Manag Care Interface. 2006;19:43–9.PubMedGoogle Scholar
  19. 19.
    Tuteja AK, Biskupiak JE. Chronic constipation: overview and treatment options. P&T. 2007;32:91–105.Google Scholar
  20. 20.
    Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.PubMedGoogle Scholar
  21. 21.
    McCrea GL, Miaskowski C, Stotts NA, et al. Pathophysiology of constipation in the older adult. World J Gastroenterol. 2008;14:2631–8.PubMedGoogle Scholar
  22. 22.
    Ashraf W, Park F, Lof J, et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol. 1996;91:26–32.PubMedGoogle Scholar
  23. 23.
    Walter SA, Kjellstrom L, Nyhlin H, et al. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010;45:556–66.PubMedGoogle Scholar
  24. 24.
    Abyad A, Mourad F. Constipation: common-sense care of the older patient. Geriatrics. 1996;51:28–34, 36.Google Scholar
  25. 25.
    Koch A, Voderholzer WA, Klauser AG, et al. Symptoms in chronic constipation. Dis Colon Rectum. 1997;40:902–6.PubMedGoogle Scholar
  26. 26.
    Pandol SJ, Raybould HE, Yee HF. Integrative response of the gastrointestinal tract and liver to a meal. In: Yamada T, Alpers DH, Kalloo AN, Kaplowitz N, Owyang C, Powell DW, editors. Textbook of gastroenterology, vol. 1. 5th ed. Oxford: Blackwell; 2009. p. 3–14.Google Scholar
  27. 27.
    Danjo K, Sakamoto J, Iwane S, et al. Effects of cellulose supplementation on fecal consistency and fecal weight. Dig Dis Sci. 2008;53:712–8.PubMedGoogle Scholar
  28. 28.
    Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008;11:651–60.PubMedGoogle Scholar
  29. 29.
    Laugier R, Bernard JP, Berthezene P, et al. Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly. Digestion. 1991;50:202–11.PubMedGoogle Scholar
  30. 30.
    Sprenger N, Julita M, Donnicola D, et al. Sialic acid feeding aged rats rejuvenates stimulated salivation and colon enteric neuron chemotypes. Glycobiology. 2009;19:1492–502.PubMedGoogle Scholar
  31. 31.
    Peck CJ, Samsuria SD, Harrington AM, et al. Fall in density, but not number of myenteric neurons and circular muscle nerve fibres in guinea-pig colon with ageing. Neurogastroenterol Motil. 2009;21:1075–e90.PubMedGoogle Scholar
  32. 32.
    Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009;21:746–e46.PubMedGoogle Scholar
  33. 33.
    Phillips RJ, Powley TL. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci. 2007;136:1–19.PubMedGoogle Scholar
  34. 34.
    Phillips RJ, Pairitz JC, Powley TL. Age-related neuronal loss in the submucosal plexus of the colon of Fischer 344 rats. Neurobiol Aging. 2007;28:1124–37.PubMedGoogle Scholar
  35. 35.
    Wiskur B, Greenwood-Van Meerveld B. The aging colon: the role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep. 2010;12:507–12.PubMedGoogle Scholar
  36. 36.
    Phillips RJ, Rhodes BS, Powley TL. Effects of age on sympathetic innervation of the myenteric plexus and gastrointestinal smooth muscle of Fischer 344 rats. Anat Embryol (Berl). 2006;211:673–83.Google Scholar
  37. 37.
    Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs. 2007;16:181–94.PubMedGoogle Scholar
  38. 38.
    Mehendale SR, Yuan CS. Opioid-induced gastrointestinal dysfunction. Dig Dis. 2006;24:105–12.PubMedGoogle Scholar
  39. 39.
    De Schepper HU, Cremonini F, Park MI, et al. Opioids and the gut: pharmacology and current clinical experience. Neurogastro­enterol Motil. 2004;16:383–94.PubMedGoogle Scholar
  40. 40.
    Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Lett. 2004;361:192–5.PubMedGoogle Scholar
  41. 41.
    Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004;16 Suppl 2:17–28.PubMedGoogle Scholar
  42. 42.
    Fox JC, Fletcher JG, Zinsmeister AR, et al. Effect of aging on anorectal and pelvic floor functions in females. Dis Colon Rectum. 2006;49:1726–35.PubMedGoogle Scholar
  43. 43.
    Wilson JA. Constipation in the elderly. Clin Geriatr Med. 1999;15:499–510.PubMedGoogle Scholar
  44. 44.
    Glass D, Roubenoff R. Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci. 2010;1211:25–36.PubMedGoogle Scholar
  45. 45.
    Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57:456–62.PubMedGoogle Scholar
  46. 46.
    Braak H, Rub U, Gai WP, et al. Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110:517–36.PubMedGoogle Scholar
  47. 47.
    Clemens KE, Klaschik E. Management of constipation in palliative care patients. Curr Opin Support Palliat Care. 2008;2:22–7.PubMedGoogle Scholar
  48. 48.
    Thomas JR, Cooney GA, Slatkin NE. Palliative care and pain: new strategies for managing opioid bowel dysfunction. J Palliat Med. 2008;11 Suppl 1:S1–19; quiz S21–2.Google Scholar
  49. 49.
    Lat I, Foster DR, Erstad B. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med. 2010;38:S175–87.PubMedGoogle Scholar
  50. 50.
    Gartlehner G, Jonas DE, Morgan LC, et al. Drug class review on constipation drug: final report [internet]. 2010/05/25th ed. Portland: Oregon Health & Science University; 2007.Google Scholar
  51. 51.
    Chang JY, Locke GR, Schleck CD, et al. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007;19:905–11.PubMedGoogle Scholar
  52. 52.
    Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14:890–900.PubMedGoogle Scholar
  53. 53.
    Bharucha AE, Phillips SF. Slow transit constipation. Gastroenterol Clin North Am. 2001;30:77–95.PubMedGoogle Scholar
  54. 54.
    O’Brien MD, Camilleri M, von der Ohe MR, et al. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol. 1996;91:2532–8.PubMedGoogle Scholar
  55. 55.
    Mertz H, Naliboff B, Mayer E. Physiology of refractory chronic constipation. Am J Gastroenterol. 1999;94:609–15.PubMedGoogle Scholar
  56. 56.
    Pezim ME, Pemberton JH, Levin KE, et al. Parameters of anorectal and colonic motility in health and in severe constipation. Dis Colon Rectum. 1993;36:484–91.PubMedGoogle Scholar
  57. 57.
    Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–35.PubMedGoogle Scholar
  58. 58.
    Remes-Troche JM, Rao SS. Neurophysiological testing in anorectal disorders. Expert Rev Gastroenterol Hepatol. 2008;2:323–35.PubMedGoogle Scholar
  59. 59.
    Rao SS. Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am. 2008;37:569–86, viii.Google Scholar
  60. 60.
    Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol. 1998;93:1042–50.PubMedGoogle Scholar
  61. 61.
    Bharucha AE, Croak AJ, Gebhart JB, et al. Comparison of rectoanal axial forces in health and functional defecatory disorders. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1164–9.PubMedGoogle Scholar
  62. 62.
    Scott SM, Gladman MA. Manometric, sensorimotor, and neurophysiologic evaluation of anorectal function. Gastroenterol Clin North Am. 2008;37:511–38, vii.Google Scholar
  63. 63.
    Schubert MC, Sridhar S, Schade RR, et al. What every gastroenterologist needs to know about common anorectal disorders. World J Gastroenterol. 2009;15:3201–9.PubMedGoogle Scholar
  64. 64.
    Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008;103:820–2.PubMedGoogle Scholar
  65. 65.
    McCallum IJ, Ong S, Mercer-Jones M. Chronic constipation in adults. BMJ. 2009;338:b831.PubMedGoogle Scholar
  66. 66.
    Cruz JV, Regadas FS, Murad-Regadas SM, et al. TRREMS procedure (transanal repair of rectocele and rectal mucosectomy with one circular stapler): a prospective multicenter trial. Arq Gastroenterol. 2011;48:3–7.PubMedGoogle Scholar
  67. 67.
    Scarlett Y. Medical management of fecal incontinence. Gastroen­terology. 2004;126:S55–63.PubMedGoogle Scholar
  68. 68.
    Kaufman Z, Eiltch E, Dinbar A. Completely obstructive colorectal cancer. J Surg Oncol. 1989;41:230–5.PubMedGoogle Scholar
  69. 69.
    Gallagher P, O’Mahony D. Constipation in old age. Best Pract Res Clin Gastroenterol. 2009;23:875–87.PubMedGoogle Scholar
  70. 70.
    Rao SS, Meduri K. What is necessary to diagnose constipation? Best Pract Res Clin Gastroenterol. 2010;25:127–40.Google Scholar
  71. 71.
    Rao SS, Tuteja AK, Vellema T, et al. Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol. 2004;38:680–5.PubMedGoogle Scholar
  72. 72.
    Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol. 2010;105:2228–34.PubMedGoogle Scholar
  73. 73.
    Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–4.PubMedGoogle Scholar
  74. 74.
    Heaton KW, O’Donnell LJ. An office guide to whole-gut transit time. Patients’ recollection of their stool form. J Clin Gastroenterol. 1994;19:28–30.PubMedGoogle Scholar
  75. 75.
    Saad RJ, Rao SS, Koch KL, et al. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol. 2010;105:403–11.PubMedGoogle Scholar
  76. 76.
    Leung FW, Rao SS. Fecal incontinence in the elderly. Gastroenterol Clin North Am. 2009;38:503–11.PubMedGoogle Scholar
  77. 77.
    Reid MC, Henderson Jr CR, Papaleontiou M, et al. Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. Pain Med. 2010;11:1063–71.PubMedGoogle Scholar
  78. 78.
    Papaleontiou M, Henderson Jr CR, Turner BJ, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2010;58:1353–69.PubMedGoogle Scholar
  79. 79.
    Williams ME. Geriatric physical diagnosis: a guide to observation and assessment. Jefferson: McFarland; 2008.Google Scholar
  80. 80.
    Tantiphlachiva K, Rao P, Attaluri A, et al. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol. 2010;8:955–60.PubMedGoogle Scholar
  81. 81.
    Qureshi W, Adler DG, Davila RE, et al. ASGE guideline: guideline on the use of endoscopy in the management of constipation. Gastrointest Endosc. 2005;62:199–201.PubMedGoogle Scholar
  82. 82.
    Moylan S, Armstrong J, Diaz-Saldano D, et al. Are abdominal X-rays a reliable way to assess for constipation? J Urol. 2010;184:1692–8.PubMedGoogle Scholar
  83. 83.
    Dharmarajan TS, Rao VSR, Pitchumoni CS. Constipation in older adults: an ancient malady, remains a management enigma. Pract Gastroenterol. 2004;28:40–65.Google Scholar
  84. 84.
    Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol. 2003;38:36–42.PubMedGoogle Scholar
  85. 85.
    Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100:1605–15.PubMedGoogle Scholar
  86. 86.
    Rao SS. Dyssynergic defecation. Gastroenterol Clin North Am. 2001;30:97–114.PubMedGoogle Scholar
  87. 87.
    Sun WM, Rao SS. Manometric assessment of anorectal function. Gastroenterol Clin North Am. 2001;30:15–32.PubMedGoogle Scholar
  88. 88.
    Karlbom U, Lundin E, Graf W, et al. Anorectal physiology in relation to clinical subgroups of patients with severe constipation. Colorectal Dis. 2004;6:343–9.PubMedGoogle Scholar
  89. 89.
    Diamant NE, Kamm MA, Wald A, et al. AGA technical review on anorectal testing techniques. Gastroenterology. 1999;116:735–60.PubMedGoogle Scholar
  90. 90.
    Rao SS, Singh S. Clinical utility of colonic and anorectal manometry in chronic constipation. J Clin Gastroenterol. 2011;44:597–609.Google Scholar
  91. 91.
    Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126:57–62.PubMedGoogle Scholar
  92. 92.
    Fletcher JG, Busse RF, Riederer SJ, et al. Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol. 2003;98:399–411.PubMedGoogle Scholar
  93. 93.
    Savoye-Collet C, Koning E, Dacher JN. Radiologic evaluation of pelvic floor disorders. Gastroenterol Clin North Am. 2008;37:553–67, viii.Google Scholar
  94. 94.
    Reiner CS, Tutuian R, Solopova AE, et al. MR defecography in patients with dyssynergic defecation: spectrum of imaging findings and diagnostic value. Br J Radiol. 2011;84:136–44.PubMedGoogle Scholar
  95. 95.
    Rentsch M, Paetzel C, Lenhart M, et al. Dynamic magnetic resonance imaging defecography: a diagnostic alternative in the assessment of pelvic floor disorders in proctology. Dis Colon Rectum. 2001;44:999–1007.PubMedGoogle Scholar
  96. 96.
    Rao SS. Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation. Clin Gastroenterol Hepatol. 2010;8:910–9.PubMedGoogle Scholar
  97. 97.
    Romero Y, Evans JM, Fleming KC, et al. Constipation and fecal incontinence in the elderly population. Mayo Clin Proc. 1996;71:81–92.PubMedGoogle Scholar
  98. 98.
    Ostaszkiewicz J, Hornby L, Millar L, et al. The effects of conservative treatment for constipation on symptom severity and quality of life in community-dwelling adults. J Wound Ostomy Continence Nurs. 2010;37:193–8.PubMedGoogle Scholar
  99. 99.
    Sikirov D. Comparison of straining during defecation in three positions: results and implications for human health. Dig Dis Sci. 2003;48:1201–5.PubMedGoogle Scholar
  100. 100.
    Rao SS, Kavlock R, Rao S. Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol. 2006;101:2790–6.PubMedGoogle Scholar
  101. 101.
    Goldstein O, Shaham Y, Naftali T, et al. Toilet reading habits in Israeli adults. Neurogastroenterol Motil. 2009;21:291–5.PubMedGoogle Scholar
  102. 102.
    Everhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci. 1989;34:1153–62.PubMedGoogle Scholar
  103. 103.
    Schnelle JF, Leung FW, Rao SS, et al. A controlled trial of an intervention to improve urinary and fecal incontinence and constipation. J Am Geriatr Soc. 2010;58:1504–11.PubMedGoogle Scholar
  104. 104.
    Oettle GJ. Effect of moderate exercise on bowel habit. Gut. 1991;32:941–4.PubMedGoogle Scholar
  105. 105.
    Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998;45:727–32.PubMedGoogle Scholar
  106. 106.
    Morley J. Water, water everywhere and not a drop to drink. J Gerontol A Biol Sci Med Sci. 2000;55:M359–60.PubMedGoogle Scholar
  107. 107.
    Lindeman RD, Romero LJ, Liang HC, et al. Do elderly persons need to be encouraged to drink more fluids? J Gerontol A Biol Sci Med Sci. 2000;55:M361–5.PubMedGoogle Scholar
  108. 108.
    Annells M, Koch T. Constipation and the preached trio: diet, fluid intake, exercise. Int J Nurs Stud. 2003;40:843–52.PubMedGoogle Scholar
  109. 109.
    Wrick KL, Robertson JB, Van Soest PJ, et al. The influence of dietary fiber source on human intestinal transit and stool output. J Nutr. 1983;113:1464–79.PubMedGoogle Scholar
  110. 110.
    Tucker DM, Sandstead HH, Logan Jr GM, et al. Dietary fiber and personality factors as determinants of stool output. Gastroenterology. 1981;81:879–83.PubMedGoogle Scholar
  111. 111.
    Tramonte SM, Brand MB, Mulrow CD, et al. The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med. 1997;12:15–24.PubMedGoogle Scholar
  112. 112.
    Voderholzer WA, Schatke W, Muhldorfer BE, et al. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol. 1997;92:95–8.PubMedGoogle Scholar
  113. 113.
    Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011;33:895–901.PubMedGoogle Scholar
  114. 114.
    Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–31.PubMedGoogle Scholar
  115. 115.
    Attaluri A, Donahoe R, Valestin J, et al. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther. 2011;33:822–8.PubMedGoogle Scholar
  116. 116.
    Gattuso JM, Kamm MA. Clinical features of idiopathic megarectum and idiopathic megacolon. Gut. 1997;41:93–9.PubMedGoogle Scholar
  117. 117.
    Trinkley KE, Porter K, Nahata MC. Prescribing patterns for the outpatient treatment of constipation in the United States. Dig Dis Sci. 2010;55:3514–20.PubMedGoogle Scholar
  118. 118.
    Siegel JD, Di Palma JA. Medical treatment of constipation. Clin Colon Rectal Surg. 2005;18:76–80.PubMedGoogle Scholar
  119. 119.
    Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60:209–18.PubMedGoogle Scholar
  120. 120.
    Fleming V, Wade WE. A review of laxative therapies for treatment of chronic constipation in older adults. Am J Geriatr Pharmacother. 2010;8:514–50.PubMedGoogle Scholar
  121. 121.
    McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 1998;12:491–7.PubMedGoogle Scholar
  122. 122.
    Pare P, Bridges R, Champion MC, et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol. 2007;21(Suppl B):3B–22.PubMedGoogle Scholar
  123. 123.
    Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum. 2001;44:1201–9.PubMedGoogle Scholar
  124. 124.
    Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–71.PubMedGoogle Scholar
  125. 125.
    Pampati V, Fogel R. Treatment options for primary constipation. Curr Treat Options Gastroenterol. 2004;7:225–33.PubMedGoogle Scholar
  126. 126.
    Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349:1360–8.PubMedGoogle Scholar
  127. 127.
    Kienzle-Horn S, Vix JM, Schuijt C, et al. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin. 2007;23:691–9.PubMedGoogle Scholar
  128. 128.
    Muller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100:232–42.PubMedGoogle Scholar
  129. 129.
    Wald A. Pathophysiology, diagnosis and current management of chronic constipation. Nat Clin Pract Gastroenterol Hepatol. 2006;3:90–100.PubMedGoogle Scholar
  130. 130.
    Arslan GG, Eser I. An examination of the effect of castor oil packs on constipation in the elderly. Complement Ther Clin Pract. 2011;17:58–62.PubMedGoogle Scholar
  131. 131.
    Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46:522–6.PubMedGoogle Scholar
  132. 132.
    Murphy J. Movement away from phenolphthalein in laxatives. JAMA. 2009;301:1770; author reply 1770.Google Scholar
  133. 133.
    Schiller LR, Emmett M, Santa Ana CA, et al. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94:933–41.PubMedGoogle Scholar
  134. 134.
    DiPalma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord. 2004;4 Suppl 2:S34–42.PubMedGoogle Scholar
  135. 135.
    Culbert P, Gillett H, Ferguson A. Highly effective new oral therapy for faecal impaction. Br J Gen Pract. 1998;48:1599–600.PubMedGoogle Scholar
  136. 136.
    Wrenn K. Fecal impaction. N Engl J Med. 1989;321:658–62.PubMedGoogle Scholar
  137. 137.
    DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95:446–50.PubMedGoogle Scholar
  138. 138.
    Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010;(7):CD007570.Google Scholar
  139. 139.
    Chassagne P, Jego A, Gloc P, et al. Does treatment of constipation improve faecal incontinence in institutionalized elderly patients? Age Ageing. 2000;29:159–64.PubMedGoogle Scholar
  140. 140.
    Hsu HJ, Wu MS. Extreme hyperphosphatemia and hypocalcemic coma associated with phosphate enema. Intern Med. 2008;47:643–6.PubMedGoogle Scholar
  141. 141.
    Farah R. Fatal acute sodium phosphate enemas intoxication. Acta Gastroenterol Belg. 2005;68:392–3.PubMedGoogle Scholar
  142. 142.
    Harish K, Tony J, Sunilkumar R, et al. Severe colitis induced by soap enemas. Indian J Gastroenterol. 2006;25:99–100.PubMedGoogle Scholar
  143. 143.
    Al-Judaibi B, Chande N, Gregor J. Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation. Can J Clin Pharmacol. 2010;17:e194–200.PubMedGoogle Scholar
  144. 144.
    Johanson JF, Morton D, Geenen J, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 2008;103:170–7.PubMedGoogle Scholar
  145. 145.
    Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358:2344–54.PubMedGoogle Scholar
  146. 146.
    Camilleri M, Beyens G, Kerstens R, et al. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009;21:1256–e117.PubMedGoogle Scholar
  147. 147.
    Lembo AJ, Kurtz CB, Macdougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886–895.e1.PubMedGoogle Scholar
  148. 148.
    Paulson DM, Kennedy DT, Donovick RA, et al. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—a 21-day treatment-randomized clinical trial. J Pain. 2005;6:184–92.PubMedGoogle Scholar
  149. 149.
    Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage. 2008;35:458–68.PubMedGoogle Scholar
  150. 150.
    Roerig JL, Steffen KJ, Mitchell JE, et al. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010;70:1487–503.PubMedGoogle Scholar
  151. 151.
    Klein H. Constipation and fecal impaction. Med Clin North Am. 1982;66:1135–41.PubMedGoogle Scholar
  152. 152.
    Erdman LH. Fecal impaction. J S C Med Assoc. 1985;81:404–5.PubMedGoogle Scholar
  153. 153.
    Hassan I, Pemberton JH, Young-Fadok TM, et al. Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg. 2006;10:1330–6; ­discussion 1336–7.Google Scholar
  154. 154.
    Nyam DC, Pemberton JH, Ilstrup DM, et al. Long-term results of surgery for chronic constipation. Dis Colon Rectum. 1997;40:273–9.PubMedGoogle Scholar
  155. 155.
    Rotholtz NA, Wexner SD. Surgical treatment of constipation and fecal incontinence. Gastroenterol Clin North Am. 2001;30:131–66.PubMedGoogle Scholar
  156. 156.
    Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129:86–97.PubMedGoogle Scholar
  157. 157.
    Chiarioni G, Heymen S, Whitehead WE. Biofeedback therapy for dyssynergic defecation. World J Gastroenterol. 2006;12:7069–74.PubMedGoogle Scholar
  158. 158.
    Drukker CA, Heij HA, Wijnaendts LC, et al. Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma. Pediatr Blood Cancer. 2009;52:396–8.PubMedGoogle Scholar
  159. 159.
    Condom E, Vidal A, Rota R, et al. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies. Virchows Arch A Pathol Anat Histopathol. 1993;423:507–11.PubMedGoogle Scholar
  160. 160.
    Viallard JF, Vincent A, Moreau JF, et al. Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction. Eur Neurol. 2005;53:60–3.PubMedGoogle Scholar
  161. 161.
    Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroen­terology. 1988;95:1279–86.PubMedGoogle Scholar
  162. 162.
    Talley NJ, Jones M, Nuyts G, et al. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003;98:1107–11.PubMedGoogle Scholar
  163. 163.
    Ness J, Hoth A, Barnett MJ, et al. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother. 2006;4:42–51.PubMedGoogle Scholar
  164. 164.
    Opie LH. Calcium channel antagonists. Part IV: side effects and contraindications drug interactions and combinations. Cardiovasc Drugs Ther. 1988;2:177–89.PubMedGoogle Scholar
  165. 165.
    Hallberg L, Ryttinger L, Solvell L. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl. 1966;459:3–10.PubMedGoogle Scholar
  166. 166.
    Trindade E, Menon D, Topfer LA, et al. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ. 1998;159:1245–52.PubMedGoogle Scholar
  167. 167.
    Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61:1181–7.PubMedGoogle Scholar
  168. 168.
    Dobben AC, Terra MP, Deutekom M, et al. Anal inspection and digital rectal examination compared to anorectal physiology tests and endoanal ultrasonography in evaluating fecal incontinence. Int J Colorectal Dis. 2007;22:783–90.PubMedGoogle Scholar
  169. 169.
    Tack J. Current and future therapies for chronic constipation. Best Pract Res Clin Gastroenterol. 2011;25:151–8.PubMedGoogle Scholar
  170. 170.
    Castle SC, Cantrell M, Israel DS, et al. Constipation prevention: empiric use of stool softeners questioned. Geriatrics. 1991;46:84–6.PubMedGoogle Scholar
  171. 171.
    Lacy BE, Brunton SA. Partnering with gastroenterologists to evaluate patients with chronic constipation. MedGenMed. 2005;7:19.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • T. S. Dharmarajan
    • 1
  • T. S. Dharmarajan
    • 2
  • T. S. Dharmarajan
    • 3
  • T. S. Dharmarajan
    • 4
  • David Widjaja
    • 5
  • C. S. Pitchumoni
    • 6
  • C. S. Pitchumoni
    • 7
  • C. S. Pitchumoni
    • 8
  1. 1.New York Medical CollegeValhallaUSA
  2. 2.Department of MedicineMontefiore Medical Center (North Division)BronxUSA
  3. 3.Division of GeriatricsMontefiore Medical Center (North Division)BronxUSA
  4. 4.Geriatric Medicine Fellowship ProgramMontefiore Medical Center (North Division)BronxUSA
  5. 5.Department of Medicine, Division of Gastroenterology, Bronx Lebanon Hospital CenterAlbert Einstein College of MedicineBronxUSA
  6. 6.Robert Wood Johnson School of Medicine, Drexel University School of MedicinePhiladelphiaUSA
  7. 7.New York Medical CollegeVallhalaUSA
  8. 8.Gastroenterology, Hepatology and NutritionSaint Peter’s University HospitalNew BrunswickUSA

Personalised recommendations